Procter & Gamble announced its fourth quarter fiscal 2024 results on July 30, 2024, achieving 2% organic sales growth despite flat net sales. Core EPS increased 2% to $1.40, while currency-neutral Core EPS rose 6% to $1.45. Core gross margin expanded by 140 basis points to 49.8%.For the full fiscal year 2024, P&G delivered 4% organic sales growth and 12% Core EPS growth to $6.59. The company's operating cash flow reached $19.85 billion, with adjusted free cash flow of $16.95 billion, representing a productivity ratio of 105%. The results included a non-cash impairment charge of $1.0 billion after-tax related to the Gillette intangible asset.Looking ahead to fiscal 2025, P&G projects organic sales growth of 3-5% and core EPS growth of 5-7%, with currency-neutral core EPS expected to increase 6-8%. The company continues to focus on operating efficiency while navigating market challenges.

Procter & Gamble announced its fourth quarter fiscal 2024 results on July 30, 2024, achieving 2% organic sales growth despite flat net sales. Core EPS increased 2% to $1.40, while currency-neutral Core EPS rose 6% to $1.45. Core gross margin expanded by 140 basis points to 49.8%.For the full fiscal year 2024, P&G delivered 4% organic sales growth and 12% Core EPS growth to $6.59. The company's operating cash flow reached $19.85 billion, with adjusted free cash flow of $16.95 billion, representing a productivity ratio of 105%. The results included a non-cash impairment charge of $1.0 billion after-tax related to the Gillette intangible asset.Looking ahead to fiscal 2025, P&G projects organic sales growth of 3-5% and core EPS growth of 5-7%, with currency-neutral core EPS expected to increase 6-8%. The company continues to focus on operating efficiency while navigating market challenges.